These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 15128425)

  • 1. Fatal Evans' syndrome after matched unrelated donor transplantation for hyper-IgM syndrome.
    Urban C; Benesch M; Sovinz P; Schwinger W; Lackner H
    Eur J Haematol; 2004 Jun; 72(6):444-7. PubMed ID: 15128425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune thrombocytopenia after umbilical cord progenitor cell transplant: response to vincristine.
    Dovat S; Roberts RL; Wakim M; Stiehm ER; Feig SA
    Bone Marrow Transplant; 1999 Aug; 24(3):321-3. PubMed ID: 10455373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unrelated umbilical cord blood transplantation in infancy for mucopolysaccharidosis type IIB (Hunter syndrome) complicated by autoimmune hemolytic anemia.
    Mullen CA; Thompson JN; Richard LA; Chan KW
    Bone Marrow Transplant; 2000 May; 25(10):1093-7. PubMed ID: 10828871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute autoimmune hemolytic anemia following unrelated cord blood transplantation as an early manifestation of chronic graft-versus-host disease.
    Sevilla J; González-Vicent M; Madero L; Díaz MA
    Bone Marrow Transplant; 2001 Jul; 28(1):89-92. PubMed ID: 11498750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of thrombocytopenia and hemolytic anemia with IvIG in a patient with lupus-like syndrome after mismatched related PBSCT.
    Hartert A; Willenbacher W; Günzelmann S; Roemer E; Basara N; Fauser AA; Kiehl MG
    Bone Marrow Transplant; 2001 Feb; 27(3):337-40. PubMed ID: 11277184
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON).
    Muñoz A; Olivé T; Martinez A; Bureo E; Maldonado MS; Diaz de Heredia C; Sastre A; Gonzalez-Vicent M;
    Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful unrelated cord blood transplantation in a 7-year-old boy with Evans syndrome refractory to immunosuppression and double autologous stem cell transplantation.
    Urban C; Lackner H; Sovinz P; Benesch M; Schwinger W; Dornbusch HJ; Moser A
    Eur J Haematol; 2006 Jun; 76(6):526-30. PubMed ID: 16529601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe autoimmune hemolytic anemia after unrelated umbilical cord blood transplant for familial hemophagocytic lymphohistiocytosis: significant improvement after treatment with rituximab.
    Radhi M; Rumelhart S; Tatman D; Goldman F
    J Pediatr Hematol Oncol; 2007 Feb; 29(2):125-7. PubMed ID: 17279011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome of pediatric hematopoietic stem cell transplantations from Thai unrelated donors matched with high-resolution HLA typing.
    Vanichsetakul P; O-Charoen R; Seksarn P; Kupatawintu P
    J Med Assoc Thai; 2005 Sep; 88 Suppl 4():S1-6. PubMed ID: 16622993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evans' syndrome following autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Kamezaki K; Fukuda T; Makino S; Harada M
    Clin Lab Haematol; 2004 Aug; 26(4):291-3. PubMed ID: 15279667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of life-threatening Evans syndrome due to antiphospholipid antibody syndrome by rituximab-based regimen: a case with long-term follow-up.
    Rückert A; Glimm H; Lübbert M; Grüllich C
    Lupus; 2008 Aug; 17(8):757-60. PubMed ID: 18625656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory Evans' syndrome treated with allogeneic SCT followed by DLI. Demonstration of a graft-versus-autoimmunity effect.
    Marmont AM; Gualandi F; Van Lint MT; Bacigalupo A
    Bone Marrow Transplant; 2003 Mar; 31(5):399-402. PubMed ID: 12634732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Excellent outcome of allogeneic hematopoietic stem cell transplantation using a conditioning regimen with medium-dose VP-16, cyclophosphamide and total-body irradiation for adult patients with acute lymphoblastic leukemia.
    Shigematsu A; Kondo T; Yamamoto S; Sugita J; Onozawa M; Kahata K; Endo T; Shiratori S; Ota S; Obara M; Wakasa K; Takahata M; Takeda Y; Tanaka J; Hashino S; Nishio M; Koike T; Asaka M; Imamura M
    Biol Blood Marrow Transplant; 2008 May; 14(5):568-75. PubMed ID: 18410899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Life-threatening graft-vs-host disease.
    Vargas-Díez E; García-Díez A; Marín A; Fernández-Herrera J
    Clin Dermatol; 2005; 23(3):285-300. PubMed ID: 15896544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematopoietic cell transplantation for mucopolysaccharidosis IIB (Hunter syndrome).
    Peters C; Krivit W
    Bone Marrow Transplant; 2000 May; 25(10):1097-9. PubMed ID: 10828872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fatal autoimmune pancytopenia following bone marrow transplantation for aplastic anaemia.
    De Lord C; Marsh JC; Smith JG; Singer CR; Gordon-Smith EC
    Bone Marrow Transplant; 1996 Jul; 18(1):237-9. PubMed ID: 8832026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.
    Valcárcel D; Martino R; Caballero D; Martin J; Ferra C; Nieto JB; Sampol A; Bernal MT; Piñana JL; Vazquez L; Ribera JM; Besalduch J; Moraleda JM; Carrera D; Brunet MS; Perez-Simón JA; Sierra J
    J Clin Oncol; 2008 Feb; 26(4):577-84. PubMed ID: 18086801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An immunological syndrome featuring transverse myelitis, Evans syndrome and pulmonary infiltrates after unrelated bone marrow transplant in a patient with severe aplastic anemia.
    Richard S; Fruchtman S; Scigliano E; Skerrett D; Najfeld V; Isola L
    Bone Marrow Transplant; 2000 Dec; 26(11):1225-8. PubMed ID: 11149736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal GvHD as a complication of liver transplantation for undetermined fulminant hepatic failure and associated aplastic anemia.
    Schäppi MG; Belli DC; Rimensberger PC; Chardot C; Kaya G; Tiercy JM; Ozsahin H
    Liver Transpl; 2006 Nov; 12(11):1693-7. PubMed ID: 17058230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.